Merck Foundation, the philanthropic arm of Merck KGaA Germany, together with First Ladies of Africa and Asia, who are also ...
Merck Foundation, the philanthropic arm of Merck KGaA Germany together with First Ladies of Africa who are also their Ambassadors, Ministries of Health, Education, Communication & Gender, mark ...
Phenom today unveiled the winners of its 2025 Talent Experience awards. The awards celebrate the extraordinary achievements ...
German science and technology giant Merck Group reported a return to growth in 2024, with net sales rising 0.8 percent ...
One of Merck KGaA’s leading immunology assets has flunked a phase 2 lupus trial. | One of Merck KGaA’s leading immunology ...
Germany’s Merck KGaA (MRK: DE) returned to profitable growth in 2024 and delivered on its guidance for the year.
2d
Clinical Trials Arena on MSNMerck KGaA’s lupus drug fails in SLE cohort of Phase II trialMerck’s lupus drug enpatoran has failed to meet the primary endpoint in a subgroup of patients, but the drug's development is ...
6d
DPA International on MSNMerck sees slight earnings, sales growth in 2025German science and technology company Merck on Thursday forecast its net sales to be in the range of €21.5 billion ($23.2 ...
Merck’s oral TLR7/8 inhibitor enpatoran has failed to meet the primary endpoint in a subgroup of patients, but development of ...
Detailed price information for Verizon Communications Inc (VZ-N) from The Globe and Mail including charting and trades.
SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results